Heart valves from Medtronic, Edwards show "encouraging" results

10/24/2011 | MassDevice.com (Boston)

A U.K. study of 877 transcatheter aortic valve implant procedures done from January 2007 to December 2009 found that patients who received Medtronic's CoreValve had lower death rates, while patients who received Edwards Lifesciences' Sapien device had reduced rates of repeat procedures and pacemaker use. Edwards anticipates FDA clearance for its device soon, while Medtronic expects its device to be available in the U.S. market by 2014.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Chicago, IL
Senior Manager, Compliance
Fremont, CA
Manager, Business Conduct
Foster City, CA
Product Patent Attorney
Foster City, CA
Employment Counsel
Foster City, CA